Item(by='mft_', descendants=None, kids=None, score=None, time=1602171510, title=None, item_type='comment', url=None, parent=24701712, text='FWIW, I was sketching out the situation in the US healthcare market generally, and not specifically referring to the insulin situation.<p>To expand slightly (all IM opinion&#x2F;observation):<p>a) Often, there isn&#x27;t a &#x27;market&#x27;, as there might not be multiple <i>competitive</i> options for each disease.<p>b) Even in situations where there are (say) two roughy similar treatments for a disease, market forces don&#x27;t always apply - manufacturers differentiate via other routes and try to avoid price erosion.<p>c) It&#x27;s uncertain how often price directly influences <i>prescribing</i> decisions (in the US, or indeed in many countries).')